Pharmaceuticals Archives - Journal of Anaesthesia Practice

28 April 2020

US FDA approves Emerphed from Nexus Pharmaceuticals

The US Food and Drug Administration has approved Emerphed, the first and only premixed ephedrine in a ready-to-use 50 mg/10...

and receive all of the latest news via our weekly newsletter

"*" indicates required fields

BROWSE BY SECTION

ABOUT
ARTICLES
BOOK REVIEWS
COMPANIES
COMPANY INTERVIEWS
EDITORIAL BOARD
EVENTS
JANUARY 2025
JUNE 2025
MAY 2025
NEWS
PRODUCT NEWS
PROMOTIONAL FEATURES

About Us

Journal of Anaesthesia Practice is a leading online title in the field of anaesthesia

Journal of Anaesthesia Practice is a unique online vehicle for getting an anaesthetic product or service in front of the people who really matter. The vast majority of the readership are consultant anaesthetists.

Pharmaceuticals

US FDA approves Emerphed from Nexus Pharmaceuticals

The teardrop explodes? An unusual thoracic anatomical variant

New CONSORT reporting guidelines published today in five medical journals

Only around 1 in 10 common non-surgical and non-invasive treatments for back pain effective

Effectively Managing Swabs With Swabsafe™

Scientists discover ‘mirrored’ pain is far more common than previously thought

Use of strong synthetic opioids during surgery linked to poor composite experience of pain

About Us

Pharmaceuticals

US FDA approves Emerphed from Nexus Pharmaceuticals

and receive all of the latest news via our weekly newsletter

The teardrop explodes? An unusual thoracic anatomical variant

New CONSORT reporting guidelines published today in five medical journals

Only around 1 in 10 common non-surgical and non-invasive treatments for back pain effective

Effectively Managing Swabs With Swabsafe™

Scientists discover ‘mirrored’ pain is far more common than previously thought

Use of strong synthetic opioids during surgery linked to poor composite experience of pain

About Us

Subscribe

and receive all of the latest news via our weekly newsletter